More on ALLO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (7.0 Score)

Upcoming Events

- Earnings (4/30/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Allogene Therapeutics (NQ:ALLO)
Delayed: 2.30 -0.01 (0.43%)
Prev. Close $2.31  
Open$2.24 
52 Wk High$ 
52 Wk Low$ 
Day High$2.31 
Day Low$2.20 
P/E N/A  
EPS$ 
Volume4,127,464 

Friends, Peers and Foes (?): ALCLS, CLLS, CHRS, ELVN, ONCY (more...)

Mar 4, 2026 05:42 PM Form 4 Allogene Therapeutics, For: Mar 02 Filed by: Beneski Benjamin Machinas
Mar 2, 2026 09:05 PM Form 144 Allogene Therapeutics, Filed by: Beneski Benjamin Machinas
Mar 2, 2026 08:30 AM Allogene Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update
Feb 17, 2026 05:34 PM Form SCHEDULE 13G/A Allogene Therapeutics, Filed by: Belldegrun Arie
Feb 13, 2026 05:10 PM Form SCHEDULE 13D/A Allogene Therapeutics, Filed by: PFIZER INC
Feb 13, 2026 04:22 PM Form SCHEDULE 13G Allogene Therapeutics, Filed by: Chang David D
Feb 5, 2026 08:30 AM Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
Feb 4, 2026 05:20 PM Form 4 Allogene Therapeutics, For: Feb 02 Filed by: Beneski Benjamin Machinas
Feb 4, 2026 05:18 PM Form 4 Allogene Therapeutics, For: Feb 02 Filed by: Chang David D
Feb 4, 2026 05:16 PM Form 4 Allogene Therapeutics, For: Feb 02 Filed by: Parker Geoffrey M.
View All Articles

Entities mentioned with ALLO

View All Entities